Cargando…

Lifestyle and emotional well-being in men and women with type 2 diabetes (e-VitaDM-4; ZODIAC-48)

Background: Whether lifestyle is associated with well-being in patients with type 2 diabetes (T2D) is largely unknown. Uncovering and clarifying associations between these constructs may lead to new strategies for improving both. Objectives: The aim was to investigate the relationship between lifest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hendriks, Steven H., van Soldt, Evelien G.W., van Vugt, Michael, Groenier, Klaas H., Roelofsen, Yvonne, Maas, Angela H. E. M., Bilo, Henk J. G., Kleefstra, Nanne, van Hateren, Kornelis J. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774266/ https://www.ncbi.nlm.nih.gov/pubmed/28326866 http://dx.doi.org/10.1080/13814788.2017.1292348

Ejemplares similares

Demographical, Clinical, and Psychological Characteristics of Users and Nonusers of an Online Platform for T2DM Patients (e-VitaDM-3/ZODIAC-44)
por: Roelofsen, Yvonne, et al.
Publicado: (2016)

Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40)
por: Roelofsen, Yvonne, et al.
Publicado: (2014)

Gender differences in the evaluation of care for patients with type 2 diabetes: a cross-sectional study (ZODIAC-52)
por: Hendriks, Steven H., et al.
Publicado: (2018)

Sex Differences in the Quality of Diabetes Care in the Netherlands (ZODIAC-45)
por: Hendriks, Steven H., et al.
Publicado: (2015)

Sex differences in survival of patients with type 2 diabetes in primary care (ZODIAC-50)
por: Hendriks, Steven H, et al.
Publicado: (2017)

Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16
por: Landman, Gijs W.D., et al.
Publicado: (2010)

A prospective observational study of quality of diabetes care in a shared care setting: trends and age differences (ZODIAC-19)
por: van Hateren, Kornelis J J, et al.
Publicado: (2012)

Health-Related Quality of Life and Mortality in a General and Elderly Population of Patients With Type 2 Diabetes (ZODIAC-18)
por: Landman, Gijs W.D., et al.
Publicado: (2010)

Addition of sulphonylurea to metformin does not relevantly change body weight: a prospective observational cohort study (ZODIAC‐39)
por: Schrijnders, Dennis, et al.
Publicado: (2016)

The Lipid Profile and Mortality Risk in Elderly Type 2 Diabetic Patients: A Ten-Year Follow-Up Study (ZODIAC-13)
por: van Hateren, Kornelis J. J., et al.
Publicado: (2009)

Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) – a study protocol
por: Schrijnders, Dennis, et al.
Publicado: (2017)

Association between body mass index and obesity-related cancer risk in men and women with type 2 diabetes in primary care in the Netherlands: a cohort study (ZODIAC-56)
por: Hendriks, Steven H, et al.
Publicado: (2018)

Association between 9p21 genetic variants and mortality risk in a prospective cohort of patients with type 2 diabetes (ZODIAC-15)
por: Landman, Gijs WD, et al.
Publicado: (2012)

The Midregional Fragment of Pro-A–Type Natriuretic Peptide, Blood Pressure, and Mortality in a Prospective Cohort Study of Patients With Type 2 Diabetes (ZODIAC-25)
por: van Hateren, Kornelis J.J., et al.
Publicado: (2013)

Serum Proenkephalin A Levels and Mortality After Long-Term Follow-Up in Patients with Type 2 Diabetes Mellitus (ZODIAC-32)
por: van Hateren, Kornelis J. J., et al.
Publicado: (2015)

Copeptin, a Surrogate Marker for Arginine Vasopressin, Is Associated With Cardiovascular and All-Cause Mortality in Patients With Type 2 Diabetes (ZODIAC-31)
por: Riphagen, Ineke J., et al.
Publicado: (2013)

Serum Peroxiredoxin 4: A Marker of Oxidative Stress Associated with Mortality in Type 2 Diabetes (ZODIAC-28)
por: Gerrits, Esther G., et al.
Publicado: (2014)

Within-Sulfonylurea-Class Evaluation of Time to Intensification with Insulin (ZODIAC-43)
por: Schrijnders, Dennis, et al.
Publicado: (2016)

Patient Activation in Type 2 Diabetes: Does It Differ between Men and Women?
por: Hendriks, Steven H., et al.
Publicado: (2016)

The relationship between N-terminal prosomatostatin, all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus (ZODIAC-35)
por: van Dijk, Peter R, et al.
Publicado: (2015)

Comparison of Methods for Renal Risk Prediction in Patients with Type 2 Diabetes (ZODIAC-36)
por: Riphagen, Ineke J., et al.
Publicado: (2015)

Validation of the howRu and howRwe questionnaires at the individual patient level
por: Hendriks, Steven H., et al.
Publicado: (2015)

Plasma COOH-Terminal Proendothelin-1: A marker of fatal cardiovascular events, all-cause mortality, and new-onset albuminuria in type 2 diabetes? (ZODIAC-29)
por: Drion, Iefke, et al.
Publicado: (2012)

Uptake and Effects of the e-Vita Personal Health Record with Self-Management Support and Coaching, for Type 2 Diabetes Patients Treated in Primary Care
por: van Vugt, M., et al.
Publicado: (2016)

Sex differences in obesity related cancer incidence in relation to type 2 diabetes diagnosis (ZODIAC-49)
por: Schrijnders, Dennis, et al.
Publicado: (2018)

Safety and Efficacy of Gliclazide as Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Trials
por: Landman, Gijs W. D., et al.
Publicado: (2014)

Type 2 diabetes seems not to be a risk factor for the carpal tunnel syndrome: a case control study
por: Hendriks, Steven H, et al.
Publicado: (2014)

Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
por: Kleefstra, Nanne, et al.
Publicado: (2009)

Improved Glycemic Control With Intraperitoneal Versus Subcutaneous Insulin in Type 1 Diabetes: A randomized controlled trial
por: Logtenberg, Susan J., et al.
Publicado: (2009)

Health-Related Quality of Life, Treatment Satisfaction, and Costs Associated With Intraperitoneal Versus Subcutaneous Insulin Administration in Type 1 Diabetes: A randomized controlled trial
por: Logtenberg, Susan J., et al.
Publicado: (2010)

Continuous intraperitoneal insulin infusion in type 1 diabetes: a 6-year post-trial follow-up
por: van Dijk, Peter R, et al.
Publicado: (2014)

Route of Insulin Does Not Influence 25-Hydroxyvitamin D Concentrations in Type 1 Diabetes: A Brief Report
por: van Dijk, Peter R, et al.
Publicado: (2019)

Effects of three frequencies of self-monitored blood glucose on HbA1c and quality of life in patients with type 2 diabetes with once daily insulin and stable control: a randomized trial
por: Hortensius, Johanna, et al.
Publicado: (2018)

Laser therapy for onychomycosis in patients with diabetes at risk for foot complications: study protocol for a randomized, double-blind, controlled trial (LASER-1)
por: Nijenhuis-Rosien, Leonie, et al.
Publicado: (2015)

Comment on: Rogers et al. Blood Pressure Trajectories Prior to Death in Patients With Diabetes. Diabetes Care 2011;34:1534–1539
por: van Hateren, K.J.J., et al.
Publicado: (2011)

Clinical evaluation of analytical variations in serum creatinine measurements: why laboratories should abandon Jaffe techniques
por: Drion, Iefke, et al.
Publicado: (2012)

Different routes of insulin administration do not influence serum free thiols in type 1 diabetes mellitus
por: van Dijk, Peter R., et al.
Publicado: (2019)

Distribution of care expenditures for men and women with type 2 diabetes treated in primary care in the Netherlands: a case–control study (ZODIAC-59)
por: Mevissen, M R J, et al.
Publicado: (2022)

Self-Monitoring of Blood Glucose: The Use of the First or the Second Drop of Blood
por: Hortensius, Johanna, et al.
Publicado: (2011)

Web-based self-management with and without coaching for type 2 diabetes patients in primary care: design of a randomized controlled trial
por: van Vugt, Michael, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fq3u450undfm10ctmskg8nfn4n